Skip to content

Hysteroscopic Intrauterine Suturing

Hysteroscopic Intrauterine Suturing by Using X-Tack - Pilot Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06656286
Enrollment
2
Registered
2024-10-24
Start date
2025-05-12
Completion date
2026-07-02
Last updated
2026-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Niche, Uterine Disease

Brief summary

Clinical trial The aim of the study is to evaluate the safety and feasibility of intrauterine suturing with Apollos X-tack, inserted into the uterus by hysteroscope. Primary outcome: Intrauterine suture will sustain the procedure - when the uterus will be opened the suture will be observed. Secondary outcome: Procedure complications. Study Design Interventional pilot Study Study group: Women undergoing laparoscopic hysterectomy.

Detailed description

Introduction: A hysteroscopy is a procedure used to examine and treat the inside of the uterus. Apollo X-tack is an endoscopic apparatus for stomach defect closure by gastroscopy. The aim of this study is to evaluate the safety and feasibility of intrauterine suturing with Apollos X-tack inserted into the uterus by hysteroscope. Study Design Interventional pilot study Study group: Women undergoing laparoscopic hysterectomy. Inclusion criteria: Benign indication for hysterectomy Exclusion from the study: Evidence or suspicious for malignancy Sample size calculation: Pilot study of 2 patients. Primary outcome: Intrauterine suture will sustain the procedure - when the uterus will be opened the suture will be observed. Secondary outcome: Procedure complications. Recruitment: The recruitment of the patients will be done at the gynecology department before the surgery. Procedure: After general anesthesia and entering the abdomen with the laparoscope, Truclear hysteroscope with X-tack attached will be inserted to the uterine cavity. Insertion of normal saline to the cavity and applying 4 points suturing to the uterus. The procedure will be monitored by external laparoscopic camera located in the abdominal cavity. After the hysterectomy the uterus will be opened and the suture will be examine. A preoperative intrauterine incision using a hysteroscope, followed by suturing, will be considered based on the success of the first procedure. CRF: Demographics information, obstetrics and gynecology information, surgery type, surgery indication. Procedure duration, success, amount of fluid used, cervical dilatation, complications.

Interventions

DEVICEIntra-Uterine suturing by X-TACK device and hysteroscope

After general anesthesia and entering the abdomen with the laparoscope, Truclear hysteroscope with X-tack attached will be inserted to the uterine cavity. Insertion of normal saline to the cavity and applying 4 points suturing to the uterus. The procedure will be monitored by external laparoscopic camera located in the abdominal cavity. After the hysterectomy the uterus will be opened and the suture will be examine. A preoperative intrauterine incision using a hysteroscope, followed by suturing, will be considered based on the success of the first procedure.

Sponsors

HaEmek Medical Center, Israel
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Benign indication for hysterectomy

Exclusion criteria

* Evidence or suspicious for malignancy

Design outcomes

Primary

MeasureTime frameDescription
Device Feasibility (intrauterine suturing) - The suture will sustain inside the uterus.Immediately after the procedure.When the uterus will be opened the suture will be observed.

Secondary

MeasureTime frame
Safety: Procedure complications - Uterine perforation, vaginal\cervical\uterine injury.Immediately after the procedure.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 19, 2026